[Action spectra of 3 anticholinergic drugs with preferential central activity (2 phenyl-2-isobutyl) ethyl pyrrolidone (1067 CERM), 2(ethyl n-propyl-amino ethyl alpha, alpha-diphenylglycolate (AP 1288) and dimethylamino-9-benziloxybicyclo (3,3,1)nonane (N1199)].
D000818:Animals; D001115:Arecoline / Q000037:antagonists & inhibitors; D001561:Benzilates / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects*; D005021:Ethylamines / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009539:Nicotinic Acids / Q000037:antagonists & inhibitors*; D010276:Parasympatholytics / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D011930:Reaction Time / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D012677:Sensation / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced
D001561:Benzilates; D005021:Ethylamines; D009539:Nicotinic Acids; D010276:Parasympatholytics; D011437:Propylamines; D011759:Pyrrolidines; C002122:1067CERM; D001115:Arecoline
Spectres d'actions de trois anticholinergiques à acitivité centrale préférentielle (2 phényl-2-isobutyl) éthyl pyrrolidine (1067 CERM), 2(éthyl n-propylamino éthyl alpha, alpha-diphénylglycolate (AP 1288) et diméthylamino-9-benziloxybicyclo (3,3,1) nonane (N 1199.